Lupin Ltd

BSE Code : 500257
NSE Symbol : LUPIN
ISIN : INE326A01037
Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

Trade Now

Get Quotes

1,931.80 -22.20(-1.14%)

Open Price (₹)

1,954.00

Prev. Close (₹)

1,954.00

Volume (No’s)

617,819

Market Cap (₹)

89,238.29

Low Price (₹)

1,927.20

High Price (₹)

1,955.80

Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Book Closure

From Date	To Date	Announcement
12-Aug-2025	NA	Re-appointment of Mr. Kanwar Bir Singh Anand as an Independent Director for second term and completion of first term of Dr. Punita Kumar-Sinha as an Independent Director of the Company.
11-Aug-2025	NA	Re-appointment of Mr. Kanwar Bir Singh Anand as an Independent Director for second term and completion of first term of Dr. Punita Kumar-Sinha as an Independent Director of the Company.
02-Jun-2025	NA	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Monday, June 2, 2025 Name of the Company Lupin Ltd ISIN INE326A01037 Scrip Code 500257 No of shares 78930 Face Value 2 Dist Nos.From Dist Nos.To 456616541 456695470 Date upto which under lock-in NA
28-May-2025	NA	Board of Directors of the Company, at its meeting held on Tuesday, February 11, 2025, inter alia, considered and unanimously approved the following: Reappointment of Ms. Vinita Gupta (DIN: 00058631) as a whole-time director designated as 'Chief Executive Officer' for a further period of five years starting May 28, 2025, on the recommendation of the Nomination and Remuneration Committee and approval of the Audit Committee, subject to the approval of the Members of the Company.
14-May-2025	NA	Lupin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2025 and recommend dividend if any. Outcome of Board Meeting - Audited Financial Results for the quarter and year ended March 31, 2025 and recommendation of Dividend Recommended a Dividend of ? 12/- (Rupees Twelve only) per Equity Share (i.e. 600%) of the face value of ? 2/- (Rupees Two only) each fully paid up, for the financial year ended March 31, 2025, subject to approval of the Members at the ensuing Annual General Meeting (AGM'). The Dividend shall be paid within 30 days from the date of approval by the Members at the ensuing AGM. (As Per BSE Announcement Dated on 14.05.2025)